Skip to content

Xper Information Management and Flex Cardio Physiomonitoring Systems

by Witt Biomedical Corp

510(k) K101571

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

2 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK101571 Date26 Oct 2010ClearedStatusActive

Recalls

8 recalls · 2 ongoing · FDA

    • Ongoing Z-1517-2021 FDA Class II initiated 29 Mar 2021

    Performance issues with the Xper Flex Cardio Physio Monitoring System include: potential delay of up to 10 seconds in displaying ECG, invasive blood pressure and other parameters; patient weight is rounded to the nearest whole kilogram;Xper IM software used with the Xper Flex Cardio Physio Monitoring System may periodically crash; No SpO2 numeric or plethysmography is displayed when SpO2 is connected o the Flex Cardio device; display of certain data from the FC2010 becomes frozen, i.e., waveforms cease sweeping and updating and the ECG, IBP, and respiration numeric values cease to update;e ECG, IBP, and respiration waveforms become flat lines and no audible alarms are produced for HR and IBP, upon start up, an unexpected non physiological ECG waveform, erratic heart rate numeric value, and non-physiological display of any other active waveforms may appear on the Boom Monitor

    • Ongoing Z-2115-2018 FDA Class II initiated 20 Nov 2017

    While in Full Disclosure playback, a user may inadvertently close the Full Disclosure Control Window using the ESC key function, instead of pressing the X icon in the upper right corner of this window.

    • Terminated Z-0614-2019 FDA Class II initiated 15 Nov 2018 on shared 510(k) K101571

    There are 3 issues: 1) Under certain conditions, real time waveforms may not be accurately plotted or displayed. 2) The oxygen saturation (SpO2) numeric value displayed on the device may freeze. 3) In auto cycle mode, if the NIBP communication is lost, the pump would not cycle and the non-invasive blood pressure (NIBP) numeric value displayed on the device would not update.

    • Completed Z-0462-2019 FDA Class II initiated 24 Sep 2018 on shared 510(k) K101571

    The Invasive Blood Pressure (IBP) numeric values will freeze on the display when any of the following functions are performed: change an IBP Site Label using the Site Label icon or the keyboard, activate or deactivate the mean pressure waveform display option (On/Off) using the Invasive Pressure Options Dialog or the keyboard, activate or deactivate the waveform hide option (On/Off) using the Invasive Pressure Options Dialog, activate or deactivate the pressure waveform filter option (On/Off) using the keyboard, and/or perform a Pullback using the Pullback icon or the keyboard

    • Terminated Z-3192-2018 FDA Class II initiated 3 Aug 2018

    Released with an incorrect, older firmware version installed. May result in intermittent loss of ECG monitoring, inaccurate ECG amplitude display and or auxiliary output, and inaccurate heart rate (HR) displayed due to QRS detection fault.

    • Terminated Z-0263-2018 FDA Class II initiated 18 Aug 2017

    Intermittent communication between the host system and the FlexCardio

    • Terminated Z-0082-2018 FDA Class II initiated 11 Aug 2017

    Intermittent communication between the host system and the Flex Cardio

    • Terminated Z-2760-2016 FDA Class II initiated 19 Oct 2015

    Display of SpO2 and Non-Invasive Blood Pressure (NIBP) Measurements May Freeze

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
MWI
Device Class
Class II
Regulation
21 CFR Part 870.2300
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Other devices from Witt Biomedical Corp

See all devices from Witt Biomedical Corp →